Lungs News and Research

RSS

Less invasive imaging system can improve cancer diagnosis

Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick and early detection of cancers.

From Osaka University 24 Jul 2020

Fusion protein found to effective at treating pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is an insidious disease. Symptoms may begin slowly, and even before they appear, extensive damage has caused the obstruction of small arteries leading to increased blood pressure in the lungs.

22 Jul 2020

Type 1 interferon deficiency in the blood could be a hallmark of severe COVID-19

Approximately 5% of people with Covid-19 progress to a severe or critical form, including the development of severe pneumonia that progresses to acute respiratory distress syndrome.

20 Jul 2020

Researchers develop novel and promising approach for treatment of lung cancer

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics.

16 Jul 2020

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

15 Jul 2020

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston.

14 Jul 2020

Severely injured donor lungs can be recovered using cross-circulation platform

Respiratory disease is the third leading cause of death worldwide, and lung transplantation is still the only cure for patients with end-stage lung disease.

14 Jul 2020

New technology can improve treatment for cystic fibrosis

World-first research led by Monash University could hold the key to better monitoring and treatment of lung disease associated with cystic fibrosis (CF) - a condition thousands of people are diagnosed with each year.

14 Jul 2020

New technology generates immune response by delivering antigens to APCs in the spleen

Red blood cells do more than shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens on their surfaces, neutralizing them, and presenting them to immune cells in the spleen and liver.

14 Jul 2020

Study shows how epigenetics contribute to the development of autoimmune diseases

The human immune system is expected to guard people against the invasion of external microbes, but at times, it possibly leads to autoimmune disorders.

From Osaka University 6 Jul 2020

Region-specific atlas reveals genome linked to human embryonic brain development

An adjusted sequence of genetic events should occur to allow the budding brain of a human embryo to turn into the organ that regulates human consciousness.

1 Jul 2020

Lab-grown 'mini-brains' can be infected by SARS-CoV-2 virus

A multidisciplinary team from two Johns Hopkins University institutions, including neurotoxicologists and virologists from the Bloomberg School of Public Health and infectious disease specialists from the school of medicine, has found that organoids (tiny tissue cultures made from human cells that simulate whole organs) known as "mini-brains" can be infected by the SARS-CoV-2 virus that causes COVID-19.

1 Jul 2020

Interconnected mycobacteria stay alive longer

The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air.

15 Jun 2020

A protein that helps to fight viruses can also inhibit lung tissue repair

Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body’s immune response to a virus, can later interfere with the repair of lung tissue.

12 Jun 2020

Lungs' immune cells can be activated more easily than previously thought

A significant site of damage during COVID-19 infection is the lungs. Understanding how the lungs' immune cells are responding to viral infections could help scientists develop a vaccine.

12 Jun 2020

Scientists aim to develop a gene-targeting, antiviral agent to combat COVID-19

A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.

5 Jun 2020

Lungs News and Research

Less invasive imaging system can improve cancer diagnosis

Fusion protein found to effective at treating pulmonary arterial hypertension

Type 1 interferon deficiency in the blood could be a hallmark of severe COVID-19

Researchers develop novel and promising approach for treatment of lung cancer

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

Severely injured donor lungs can be recovered using cross-circulation platform

New technology can improve treatment for cystic fibrosis

New technology generates immune response by delivering antigens to APCs in the spleen

Study shows how epigenetics contribute to the development of autoimmune diseases

Region-specific atlas reveals genome linked to human embryonic brain development

Lab-grown 'mini-brains' can be infected by SARS-CoV-2 virus

Interconnected mycobacteria stay alive longer

A protein that helps to fight viruses can also inhibit lung tissue repair

Lungs' immune cells can be activated more easily than previously thought

Scientists aim to develop a gene-targeting, antiviral agent to combat COVID-19

Study reveals how respiratory syncytial virus breaks into cells to cause infection

Synthetic red blood cells mimic favorable properties of natural ones

Dramatic increase in immune cells in mouse lungs after birth may help protect against infections

Inhibiting host cell proteases can help prevent COVID-19 infection

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics